Physician profile
Bianca Evelyn Carson
NPI 1033646575
$4,611.73
in general payments reported to CMS, 2019-2025
9 companies · $2,847 in 2025
The $2,847 reported for 2025 was more than what 78% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,203 · 2022: $398 · 2023: $87.18 · 2024: $76.31 · 2025: $2,847.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,600 · Food and Beverage: $411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,600.00 |
| Food and Beverage | $410.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,600.00 | 2025 | Shingrix |
| Nevro Corp. | $1,067.51 | 2021 | |
| Spr Therapeutics, INC | $591.74 | 2021-2025 | Sprint Pns System |
| Abbvie INC. | $193.84 | 2022-2025 | Botox |
| Lilly USA, LLC | $82.45 | 2021 | |
| Nalu Medical, INC. | $38.39 | 2021-2022 | |
| Allergan, INC. | $24.35 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $12.49 | 2021 | |
| Travere Therapeutics, INC. | $0.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bianca Carson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.